Wall Street Analyst Thinks Viking Stock Could Soar 188%
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Choosing the right rewards program can significantly impact your benefits. Learn which one suits you best.
27,839 articlesA wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Strive raises the dividend on SATA preferred stock to 12.75% and deploys $50 million into Strategy's STRC, while incr...
Coinbase and AWS unveiled a joint program allowing publishers on CloudFront and WAF to monetize AI-driven content acc...
Qualcomm stock slid again in early March as Bank of America launched an Underperform rating, even after the company p...
When a foreign gift becomes a temporary presidential plane, it illuminates how public spending, asset management, and...
Biotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
Two senior DeepMind researchers left within 48 hours, jolting Alphabet's AI strategy and sending shockwaves through t...
Goldman Sachs flags three natural gas stocks as strong buy candidates as LNG demand tightens and energy markets swing.
SpaceX saw a sharp weekly decline as bond-market concerns weighed on sentiment. Analysts flag Starlink expansion, AI ...
Israel launched airstrikes on Iran’s nuclear facilities, drawing Iran’s vow of retaliation and sending tremors throug...
Medicare will cover GLP-1 weight-loss drugs for eligible beneficiaries beginning this week, a policy shift that could...
Strategy reported a $12.54 billion Q1 loss driven by unrealized BTC declines, even as its software business expanded ...